$30 Billion Deal, page-2486

Ok, just so we are clear here. Covid and its impact has changed the landscape as far the medical industry and bio companies go about approaching it.
The next generation of antivirals of which bit225 is one, if successful and effective will command a significant market price depending on what virus GROUP it addresses.
BP have set the cost bar at large government budget melting numbers. Nice stupendous annual profits from in some cases very long and expensive development programs.
So if you have new antiviral that addresses the nimble covid virus across numerous versions that is effective in populations up to 48 hours after infection and can be stored on a shelf, what kind of number could you DEMAND for that?
Someone quoted a 19Billion annual market for covid a.v.

Pretty sure the week's taking to get finalised is due in part to encourage the possible future owners to stump up.
Pretty keen to be and remain part of this until it becomes a known.
i have a decent investment here, if it is all a sham... ouch, but if it's the real deal?

Just wow.

oh and ah human pregnancy is ah 40 weeks. Give or take.